Other degenerative diseases of basal ganglia
Chapter 6:Diseases of the nervous system
ICD-10 G23 is a billable code used to indicate a diagnosis of other degenerative diseases of basal ganglia.
G23 encompasses a variety of degenerative diseases affecting the basal ganglia, which are critical for coordinating movement and regulating motor control. This category includes conditions such as Parkinson's disease, which is characterized by tremors, rigidity, bradykinesia, and postural instability. Extrapyramidal disorders, which may arise from the use of certain medications or as a result of neurodegenerative diseases, also fall under this code. Movement disorders, including dystonia and chorea, can be associated with basal ganglia dysfunction. The basal ganglia's role in dopaminergic signaling is crucial, as many of these conditions are linked to dopamine deficiency or receptor dysfunction. Treatment often involves dopaminergic medications, such as levodopa, which can alleviate symptoms but may lead to complications like motor fluctuations and dyskinesias over time. Accurate coding for G23 requires a thorough understanding of the patient's clinical presentation and the underlying pathophysiology of their condition, as well as the impact of treatment regimens on their health status.
Detailed neurological examination findings, including motor function assessments and response to dopaminergic therapy.
Patients presenting with tremors, rigidity, or bradykinesia; follow-up visits for medication management.
Ensure clarity in documenting the specific type of movement disorder and any comorbid conditions.
Assessment of psychiatric symptoms related to movement disorders, including depression or anxiety associated with chronic illness.
Patients with Parkinson's disease experiencing mood disorders or cognitive decline.
Document the interplay between psychiatric symptoms and movement disorders for accurate coding.
Used for follow-up visits for patients with G23 to assess symptoms and medication efficacy.
Document the patient's symptoms, treatment plan, and any changes in condition.
Neurologists should ensure comprehensive neurological assessments are included.
G23 includes various degenerative diseases of the basal ganglia that do not fall under more specific categories like Parkinson's disease or secondary parkinsonism. This may include atypical parkinsonian syndromes and other movement disorders.
